Effectiveness outcomes
SECONDARY
Effectiveness of mPATH™-CRC is evaluated based on completion of CRC screening as determined through the nested pragmatic study.A key secondary outcome is mPATH™-CRC Effectiveness, which is defined as the proportion of patients aged 50–74 who are eligible for CRC screening who complete CRC screening within 16 weeks of their visit to the clinic. Effectiveness is determined by comparing the proportion who complete screening in a pre-implementation cohort (months 12–4 before implementation) to a post-implementation cohort (months 1–8 after implementation).An additional secondary outcome is having a CRC screening test ordered. The outcome is defined as the proportion of patients aged 50–74 who are eligible for CRC screening who have a CRC screening test ordered (colonoscopy, flexible sigmoidoscopy, fecal testing for blood, or fecal DNA testing) within 16 weeks of their visit to the clinic. This outcome will also be compared between the pre- and post-implementation cohorts.